In the present study, we found ATR-1 exhibited dose-dependent anti-tumor effects on human bladder cancer cells such as causing cell cycle arrest, inducing apoptosis and inhibition of PI3K/Akt/mTOR signaling pathway. This evidence concerns the gene PIK3CA and urinary bladder cancer.